Form D · Other Health Care

Previvo Genetics, Inc.

San Carlos, CA · CIK 0001657001

Offering snapshot reported Jan 14, 2019 · SEC filing

Reported sold
$0
Offering amount: $10M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 2, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 14, 2019Initial$0No comparison0SEC filing
Sep 23, 2016Initial$3,413,630No comparison18SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$500K (estimated)
Finders' fees
$0
Form D file number
021-330425

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Objective Capital PartnersNoneBA Securities, LLC · CRD 153489

Source: Form D, filed Jan 14, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Buster Director
John E Buster Director
Steven K Buster Director
Moses Cesario Director, Executive
Thomas Hershner Promoter
Dan Jannney Director
Todd Johnson Executive
Erin Mc Gurk Director
Santiago Munne Director
Bryan Wilson Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1599 Industrial Road
San Carlos, CA, 94070